These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 9577515

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events.
    Cates CJ, Lasserson TJ, Jaeschke R.
    Cochrane Database Syst Rev; 2009 Jul 08; (3):CD006922. PubMed ID: 19588410
    [Abstract] [Full Text] [Related]

  • 5. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.
    Pearce N, Grainger J, Atkinson M, Crane J, Burgess C, Culling C, Windom H, Beasley R.
    Thorax; 1990 Mar 08; 45(3):170-5. PubMed ID: 2330548
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity.
    Garrett JE, Lanes SF, Kolbe J, Rea HH.
    Thorax; 1996 Nov 08; 51(11):1093-9. PubMed ID: 8958891
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characteristics of users of inhaled long-acting beta 2-agonists in a southern European population.
    Castellsague J, Garcia-Rodríguez LA, Pérez-Gutthann S, Agostinis L, Cattaruzi C, Troncon MG.
    Respir Med; 1999 Oct 08; 93(10):709-14. PubMed ID: 10581659
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul 08; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Salmeterol versus theophylline in the treatment of asthma.
    Pollard SJ, Spector SL, Yancey SW, Cox FM, Emmett A.
    Ann Allergy Asthma Immunol; 1997 May 08; 78(5):457-64. PubMed ID: 9164358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.